Clinical prognostic analysis of the core genes TREM2, TTC39A, GDF15, and ANXA2 demonstrated that their expression levels were significantly correlated with the survival outcomes of patients diagnosed with HCC. Here, GDF15 is linked to hepatocellular carcinoma.